Zobrazeno 1 - 10
of 2 999
pro vyhledávání: '"Schlomm"'
Autor:
Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 5909-5917 (2018)
Martina Kluth,1,* Heinke Volta,1,* Mohammad Hussein,1 Billurvan Taskin,1 Sohall Frogh,1 Christina Möller-Koop,1 Franziska Büscheck,1 Frank Jacobsen,1 Maria Christina Tsourlakis,1 Andreas M Lübke,1 Andrea Hinsch,1 Till Clauditz,1 Markus Graefen,2 H
Externí odkaz:
https://doaj.org/article/9a267aee43fb4c788c1f52a2ef132b3c
Autor:
Göbel C, Özden C, Schroeder C, Hube-Magg C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon R, Sauter G, Michl U, Pehrke D, Huland H, Graefen M, Schlomm T, Luebke AM
Publikováno v:
Cancer Management and Research, Vol Volume 10, Pp 5491-5504 (2018)
Cosima Göbel,1,* Cansu Özden,1,* Cornelia Schroeder,2 Claudia Hube-Magg,1 Martina Kluth,1 Christina Möller-Koop,1 Emily Neubauer,1 Andrea Hinsch,1 Frank Jacobsen,1 Ronald Simon,1 Guido Sauter,1 Uwe Michl,3 Dirk Pehrke,3,4 Hartwig Huland,3 Markus G
Externí odkaz:
https://doaj.org/article/c800b60d2e994b08b3f460851efa2587
Autor:
Jacob Schmidt, Lutz Liefeldt, Emre Baysal, Stella Töpfer, Julia Dagnæs-Hansen, Markus Lerchbaumer, Thorsten Schlomm, Bernhard Ralla, Frank Friedersdorff, Robert Peters
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background IgA nephropathy (IgAN) is a common primary glomerulonephritis leading to end-stage renal disease. Living donor kidney transplantation (LDKT) is considered a favorable treatment option, but IgAN recurrence rates and the impact on o
Externí odkaz:
https://doaj.org/article/72b1d22595fb4aa9b79dbedcdecfcd12
Autor:
Henning Plage, Kira Furlano, Jörg Neymeyer, Sarah Weinberger, Benedikt Gerdes, Mandy Hubatsch, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela deMartino, Florian Roßner, Simon Schallenberg, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Henrik Zecha, Marcin Slojewski
Publikováno v:
BJUI Compass, Vol 5, Iss 6, Pp 585-592 (2024)
Abstract Objectives Carcinoembryonic antigen (CEA) is a cell surface glycoprotein that represents a promising therapeutic target. Serum measurement of shedded CEA can be utilized for monitoring of cancer patients. Material and Methods To evaluate the
Externí odkaz:
https://doaj.org/article/81a61db9b6264355b1ed85e97fb6d1fe
Autor:
Henning Plage, Kira Furlano, Sebastian Hofbauer, Sarah Weinberger, Bernhard Ralla, Antonia Franz, Annika Fendler, Michela de Martino, Florian Roßner, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Henrik Zecha, Sarah Minner, Ronald Simon, Guido Sauter, Joachim Weischenfeldt, Tobias Klatte, Thorsten Schlomm, David Horst, Simon Schallenberg
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship between PD-L1 expression and the nat
Externí odkaz:
https://doaj.org/article/2e11c11592e44f26b250abef630710aa
Autor:
Heinrich Schulte-Baukloh, Catarina Weiss, Thorsten Schlomm, Sarah Weinberger, Hendrik Borgmann, Dirk Höppner, Kathrin Haberecht, Jörg Neymeyer
Publikováno v:
Toxins, Vol 16, Iss 9, p 395 (2024)
Overactive bladder (OAB) has a significant impact on the quality of life; thus, it requires treatment that can be adhered to over a long period without undue side effects. The current treatment which uses an anticholinergic or β-3 agonist may fail t
Externí odkaz:
https://doaj.org/article/8fee1936605f445e9f6e302eec655fdf
Autor:
Debatin, Nicolaus F., Bady, Elena, Mandelkow, Tim, Huang, Zhihao, Lurati, Magalie C.J., Raedler, Jonas B., Müller, Jan H., Vettorazzi, Eik, Plage, Henning, Samtleben, Henrik, Klatte, Tobias, Hofbauer, Sebastian, Elezkurtaj, Sefer, Furlano, Kira, Weinberger, Sarah, Giacomo Bruch, Paul, Horst, David, Roßner, Florian, Schallenberg, Simon, Marx, Andreas H., Fisch, Margit, Rink, Michael, Slojewski, Marcin, Kaczmarek, Krystian, Ecke, Thorsten H., Hallmann, Steffen, Koch, Stefan, Adamini, Nico, Lennartz, Maximilian, Minner, Sarah, Simon, Ronald, Sauter, Guido, Zecha, Henrik, Schlomm, Thorsten, Blessin, Niclas C.
Publikováno v:
In European Urology July 2024 86(1):42-51
Autor:
Jan H. Müller, Henning Plage, Sefer Elezkurtaj, Tim Mandelkow, Zhihao Huang, Magalie C. J. Lurati, Jonas B. Raedler, Nicolaus F. Debatin, Eik Vettorazzi, Henrik Samtleben, Sebastian Hofbauer, Kira Furlano, Jörg Neymeyer, Irena Goranova, Bernhard Ralla, Sarah Weinberger, David Horst, Florian Roßner, Simon Schallenberg, Andreas H. Marx, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Maximilian Lennartz, Sarah Minner, Ronald Simon, Guido Sauter, Henrik Zecha, Thorsten Schlomm, Elena Bady
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionTrophoblast cell surface antigen 2 (TROP2; EpCAM2) is a transmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1). Both proteins share partial overlapping functions in epithelial development and EpCAM expression but hav
Externí odkaz:
https://doaj.org/article/e1665b34d1bc44738c48bdeeea0208d5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.